Relay Therapeutics, Inc. RLAY Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Relay Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s earnings yield?
- Relay Therapeutics, Inc. (RLAY) reported earnings yield of -15.3% in Q1 2026.
- How has Relay Therapeutics, Inc.'s earnings yield changed year-over-year?
- Relay Therapeutics, Inc.'s earnings yield increased by 79.6% year-over-year, from -75.1% to -15.3%.
- What is the long-term trend for Relay Therapeutics, Inc.'s earnings yield?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s earnings yield has grown at a 14.6% compound annual growth rate (CAGR), from -10.9% to -18.9%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.